The effect of pore diameter on neo-tissue formation in electrospun biodegradable tissue-engineered arterial grafts in a large animal model

被引:35
|
作者
Matsuzaki, Yuichi [1 ]
Iwaki, Ryuma [1 ]
Reinhardt, James W. [1 ]
Chang, Yu-Chun [1 ,2 ]
Miyamoto, Shinka [1 ]
Kelly, John [1 ]
Zbinden, Jacob [1 ,3 ]
Blum, Kevin [1 ,3 ]
Mirhaidari, Gabriel [1 ,2 ]
Ulziibayar, Anudari [1 ]
Shoji, Toshihiro [1 ]
Breuer, Christopher K. [1 ,4 ]
Shinoka, Toshiharu [1 ,4 ,5 ]
机构
[1] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Regenerat Med, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Biomed Engn Grad Program, Columbus, OH 43210 USA
[4] Ohio State Univ, Nationwide Childrens Hosp, Dept Surg, Columbus, OH 43210 USA
[5] Nationwide Childrens Hosp, Heart Ctr, Dept Cardiothorac Surg, 700 Childrens Dr,T2294, Columbus, OH 43205 USA
关键词
Tissue engineering; Vascular graft; Biodegradable; Artery; Pore diameter; Large animal model; VASCULAR GRAFTS; POLARIZATION; FIBERS;
D O I
10.1016/j.actbio.2020.08.011
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
To date, there has been little investigation of biodegradable tissue engineered arterial grafts (TEAG) using clinically relevant large animal models. The purpose of this study is to explore how pore size of electrospun scaffolds can be used to balance neoarterial tissue formation with graft structural integrity under arterial environmental conditions throughout the remodeling process. TEAGs were created with an outer poly-epsilon-caprolactone (PCL) electrospun layer and an inner sponge layer composed of heparin conjugated 50:50 poly (l-lactide-co-epsilon-caprolactone) copolymer (PLCL). Outer electrospun layers were created with four different pore diameters (4, 7, 10, and 15 mu m). Fourteen adult female sheep underwent bilateral carotid artery interposition grafting (n = 3-4 /group). Our heparin-eluting TEAG was implanted on one side (n = 14) and ePTFE graft (n = 3) or non-heparin-eluting TEAG (n = 5) on the other side. Twelve of the fourteen animals survived to the designated endpoint at 8 weeks, and one animal with 4 mu m pore diameter graft was followed to 1 year. All heparin-eluting TEAGs were patent, but those with pore diameters larger than 4 mu m began to dilate at week 4. Only scaffolds with a pore diameter of 4 mu m resisted dilation and could do so for up to 1 year. At 8 weeks, the 10 mu m pore graft had the highest density of cells in the electrospun layer and macrophages were the primary cell type present. This study highlights challenges in designing bioabsorbable TEAGs for the arterial environment in a large animal model. While larger pore diameter TEAGs promoted cell infiltration, neotissue could not regenerate rapidly enough to provide sufficient mechanical strength required to resist dilation. Future studies will be focused on evaluating a smaller pore design to better understand long-term remodeling and determine feasibility for clinical use. Statement of Significance In situ vascular tissue engineering relies on a biodegradable scaffold that encourages tissue regeneration and maintains mechanical integrity until the neotissue can bear the load. Species-specific differences in tissue regeneration and larger mechanical forces often result in graft failure when scaling up from small to large animal models. This study utilizes a slow-degrading electrospun PCL sheath to reinforce a tissue engineered arterials graft. Pore size, a property critical to tissue regeneration, was controlled by changing PCL fiber diameter and the resulting effects of these properties on neotissue formation and graft durability was evaluated. This study is among few to report the effect of pore size on vascular neotissue formation in a large animal arterial model and also demonstrate robust neotissue formation. (C) 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:176 / 184
页数:9
相关论文
共 50 条
  • [31] Decellularized bovine reinforced vessels for small-diameter tissue-engineered vascular grafts
    Grandi, Claudio
    Baiguera, Silvia
    Martorina, Francesca
    Lora, Silvano
    Amista, Pietro
    Dalzoppo, Daniele
    Del Gaudio, Costantino
    Bianco, Alessandra
    Di Liddo, Rosa
    Conconi, Maria Teresa
    Parnigotto, Pier Paolo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (03) : 315 - 325
  • [32] Challenges and Strategies for Endothelializing Decellularized Small-Diameter Tissue-Engineered Vessel Grafts
    Ding, Heng
    Hou, Xiaojie
    Gao, Zhen
    Guo, Yingqiang
    Liao, Bin
    Wan, Juyi
    ADVANCED HEALTHCARE MATERIALS, 2024, 13 (16)
  • [33] Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model
    Brennan, Matthew P.
    Dardik, Alan
    Hibino, Narutoshi
    Roh, Jason D.
    Nelson, Gregory N.
    Papademitris, Xenophon
    Shinoka, Toshiharu
    Breuer, Christopher K.
    ANNALS OF SURGERY, 2008, 248 (03) : 370 - 376
  • [34] Tissue-engineered autologous peritoneal grafts for bladder reconstruction in a porcine model
    Chen, Biao
    Chen, Xia
    Wang, Wenjia
    Shen, Jun
    Song, Zhiqiang
    Ji, Haoyu
    Zhang, Fangyuan
    Wu, Jianchen
    Na, Jie
    Li, Shengwen
    JOURNAL OF TISSUE ENGINEERING, 2021, 12
  • [35] Tissue-engineered autologous peritoneal grafts for bladder reconstruction in a porcine model
    Chen, Biao
    Chen, Xia
    Wang, Wenjia
    Shen, Jun
    Song, Zhiqiang
    Ji, Haoyu
    Zhang, Fangyuan
    Wu, Jianchen
    Na, Jie
    Li, Shengwen
    Journal of Tissue Engineering, 2021, 12
  • [36] Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation
    Best, Cameron
    Fukunishi, Takuma
    Drews, Joseph
    Khosravi, Ramak
    Hor, Kan
    Mahler, Nathan
    Yi, Tai
    Humphrey, Jay D.
    Johnson, Jed
    Breuer, Christopher K.
    Hibino, Narutoshi
    TISSUE ENGINEERING PART A, 2018, 24 (15-16) : 1251 - 1261
  • [37] Effects of Endochondral and Intramembranous Ossification Pathways on Bone Tissue Formation and Vascularization in Human Tissue-Engineered Grafts
    Bernhard, Jonathan C.
    Presen, Darja Marolt
    Li, Ming
    Monforte, Xavier
    Ferguson, James
    Leinfellner, Gabriele
    Heimel, Patrick
    Betti, Susanna L.
    Shu, Sharon
    Teuschl-Woller, Andreas H.
    Tangl, Stefan
    Redl, Heinz
    Vunjak-Novakovic, Gordana
    CELLS, 2022, 11 (19)
  • [38] Animal experimental evaluation of growth adaptation in in vivo tissue-engineered "biotube" vascular grafts
    Furukoshi, M.
    Iwai, R.
    Moriwaki, T.
    Nakayama, Y.
    EUROPEAN HEART JOURNAL, 2015, 36 : 868 - 869
  • [39] Systematic evaluation of a tissue-engineered bone for maxillary sinus augmentation in large animal canine model
    Wang, Shaoyi
    Zhang, Zhiyuan
    Xia, Lunguo
    Zhao, Jun
    Sun, Xiaojuan
    Zhang, Xiuli
    Ye, Dongxia
    Uludag, Hasan
    Jiang, Xinquan
    BONE, 2010, 46 (01) : 91 - 100
  • [40] Improvement of a Novel Small-diameter Tissue-engineered Arterial Graft With Heparin Conjugation
    Matsuzaki, Yuichi
    Miyamoto, Shinka
    Miyachi, Hideki
    Iwaki, Ryuma
    Shoji, Toshihiro
    Blum, Kevin
    Chang, Yu-Chun
    Kelly, John
    Reinhardt, James W.
    Nakayama, Hidetaka
    Breuer, Christopher K.
    Shinoka, Toshiharu
    ANNALS OF THORACIC SURGERY, 2021, 111 (04): : 1234 - 1241